NutraShure to showcase new ingredients at SupplySide West 2024

Photo © adobestock.com/vectorfusionart

NutraShure, a nutraceutical ingredient distributor, will be returning to Las Vegas, Nevada, from October 30-31, 2024. Founded in 2021, the company hopes to improve the length and quality of life of their consumers and that aging doesn’t need to be connected with a lower quality of life, according to a recent press release.

For the SupplySide West 2024 show, NutraShure will spotlight two new ingredients called BIOMEnd and SA3X. The company will also showcase their legacy ingredients 3DPump Breakthrough, and Polynol.

As mentioned in the press release, the company provides some further details on these ingredients:

• BIOMEnd: According to the company, this is the first patent-pending tasteless butyrate on the market. Butyrate is a four-carbon short-chain fatty acid that naturally occurs in certain foods, and is produced by gut bacteria during the fermentation of dietary fibers. The company says that BIOMEnd is a unique composition formulated as L-Lysine Butyrate, allowing it to have good solubility in liquids, setting it apart from other butyrate ingredients on the market, and eliminating any concerns regarding taste, uneven distribution, and sedimentation. BIOMEnd is applicable across solid dose use as well as in gummies, chocolates, and other food products.
• SA3X: This clinically studied ingredient derived from the Spilanthes acmella plant, has a long history of use in traditional folk medicine and now used in mens’ health formulations and nutritional products. Clinical studies have shown that the ingredient may increase men's muscle size, strength, and sexual satisfaction. In one study, 326 healthy sexually active men used SA3X for three months. Researchers observed a significant increase in mean serum testosterone levels after only two months of use.¹ In a randomized, placebo-controlled study of 448 men, participants taking the ingredient reported an 80% increase in sexual satisfaction after only 8 weeks, with most reporting results within the first 7 days.² SA3X is also versatile, with broad applicability across solid dose use (capsules, tablets, RTM powders), as well as in RTD beverages.
• 3DPump Breakthrough: This triple action ingredient combines the following:
  • L-Citrulline: an amino acid that enhances nitric oxide production and blood flow.
  • High-yield glycerol: aids in enhanced cell volume and fullness to support exercise tolerance in terms of time-to-exhaustion by approximately 24%.
  • Amla fruit (phyllanthus embolic): an Ayurvedic botanical, this ingredient helps bolster the bioavailability of nitric oxide and enhances general vitality, cognition, as well as longevity.
  • When combined, the 3-in-1 formula is meant to deliver muscle volumization potential, support performance, reduce perceived exertion, and support stamina, especially in heat-stress environments.
• Polynol: A natural sugarcane extract rich in polyphenols, flavonoids, and proanthocyanidins is designed to reduce oxidative stress and support healthy blood glucose. According to the company, studies have shown that Polynol significantly improves insulin response in metabolically compromised individuals while pre-clinical data suggests that it could also have photo-protective effects, supporting healthy skin appearance and UV skin protection.

NutraShure’s variety of ingredients are available in several daily dosage formats such as, 250-1,000 mg, 500 mg, 1,000 mg, and 6,000 mg which can also be utilized in various types of delivery.

To learn more about NutraShure’s profile of ingredients, please visit them at this year's SupplySide West at Booth #2516.

References

1. Patnaik, N.; Mishra, K.G.; Pradhan, N.R. Evaluation of Serum Testosterone Levels Following Three Months of SA3X (Spilanthes acmella) Supplementation. Cureus, 2022, 14 (6): e26236. DOI: 10.7759/cureus.26236
2. Patnaik, N.; Mishra, K.G.; Pradhan, N.R. Randomized, Triple-Blinded, Placebo-Controlled Trial of SA3X (Spilanthes acmella) for the Management of Erectile Dysfunction. Cureus, 2022, 14 (4): e23989. DOI: 10.7759/cureus.23989